Search clinical trials for: abobotulinum toxin lateral orbital lines

Total 4267 results

William Beaumont Hospitals

Terminated

OnabotulinumtoxinA Bladder Injection Study

Overactive Bladder | Urinary Bladder, Overactive | Urinary Incontinence | Overactive Bladder Syndrome | Urinary Urgency | Urinary Frequency/Urgency

United States
Revance Therapeutics, Inc.
Syneos Health

Completed

Long-Term Safety and Efficacy of Repeat Treatments of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia (ASPEN-OLS) (ASPEN-OLS)

Cervical Dystonia

United States, Spain, Germany, France, Czechia, Poland, United Kingdom, Canada, Austria
Weill Medical College of Cornell University
Allergan

Terminated

The Movement of Botulinum Toxin Through the Lateral Gastrocnemius Muscle in Humans: An Expanded Examination

Stroke | Muscle Spasticity

United States
Norwegian University of Science and Technology
St. Olavs Hospital

Completed

Botox Injections for Patients With Persistent Facial Pain

Facial Pain

Norway
Ipsen

Terminated

Dysport in Vulvodynia Phase II Study (DYVINIA)

Vulvodynia

United States, Canada
Northwestern University

Completed

Botox and Suction-Curettage for Treatment of Excessive Underarm Sweating (Axillary Hyperhidrosis)

Axillary Hyperhidrosis

United States
Northwestern University

Withdrawn

Botox for Gummy Smile

Gingival Exposure

United States
Northwestern University
Medicis Pharmaceutical Corporation

Completed

Treatment of Forehead/Glabellar Rhytide Complex With Combination Botulinum Toxin A and Hyaluronic Acid Versus Botulinum Toxin A Injection Alone

Forehead/Glabellar Rhytid Complexes

United States
Peking University

Completed

Application of Botulinum Toxin at the Yonsei Point for the Treatment of Gummy Smile

Botulinum Toxins, Type A | Smiling

China
Allergan

Completed

Intradermal (ID) BOTOX in the Treatment of Facial Fine Lines

Facial Fine Lines

United States
Hugel

Completed

Evaluate the Safety and Efficacy of Botulax® in Subjects With Benign Masseteric Hypertrophy

Benign Masseteric Hypertrophy

Korea, Republic of
Norwegian University of Science and Technology
St. Olavs Hospital

Completed

Botulinum Toxin Type A Block of the Sphenopalatine Ganglion in Chronic Rhinosinusitis With Nasal Polyposis

Rhinitis | Chronic Disease | Nasal Polyposis

Norway
The University of Texas Health Science Center,...

Completed

Botulinum Toxin to Improve Cosmesis of Primary Cleft Lip Repair

Cleft Palate | Cleft Lip | Scarring

United States
State University of New York - Downstate Medical...
Allergan Sales, LLC

Completed

Combination Facial Aesthetic Treatment in Millennials

Dermatological Non-Disease

United States
Faculdade de Ciências Médicas da Santa Casa de...

Completed

The Treatment of Shoulder Pain in Hemiplegic Spastic Patients With Botulinum Toxin A (dolomtox)

Shoulder Pain

Brazil
University Hospital, Strasbourg, France

Active, not recruiting

Trial Comparing Botulin Toxin Versus Hyaluronic Acid by Intra-articular Injection for the Treatment of Painful Knee Osteoarthritis (GOTOX)

Painful Unilateral Femorotibial Knee Osteoarthritis of Any Etiology

France
Allergan

Completed

BOTOX® Intravesical Instillation in Participants With Overactive Bladder and Urinary Incontinence (APOLLO)

Urinary Incontinence | Overactive Bladder With Urinary Incontinence

United States, Canada
Helse Stavanger HF

Withdrawn

Glabellar Botulinum Toxin Injections for the Treatment of Geriatric Depression (BOTDEP)

Major Depressive Disorder | Treatment Resistant Depression | Major Depressive Episode
Merz Pharmaceuticals GmbH

Completed

Clinical Study to Investigate the Efficacy and Safety of NT 201 Compared to Placebo in the Treatment of Chronic Troublesome Drooling Associated With Neurological Disorders and/or Intellectual Disability (SIPEXI)

Stroke | Cerebral Palsy | Intellectual Disability | Traumatic Brain Injury | Chronic Troublesome Sialorrhea

Georgia, Hungary, Poland, Russian Federation, Serbia, Ukraine
Protox Inc.

Completed

The Safety and Efficacy Study of PROTOXIN in Subjects With Moderate to Severe Glabellar Lines

Glabellar Frown Lines

Korea, Republic of
Merz Pharmaceuticals GmbH

Completed

Dose-response Study of Efficacy and Safety of Botulinum Toxin Type A to Treat Spasticity of the Leg(s) in Cerebral Palsy

Lower Limb Spasticity Due to Cerebral Palsy

Poland, Austria, Czechia, Estonia, France, Germany, Israel, Korea, Republic of, Romania, Russian Federation, Slovakia, Spain, Turkey, Ukraine
Merz Pharmaceuticals GmbH

Completed

Dose-response Study of Efficacy and Safety of Botulinum Toxin Type A to Treat Spasticity of the Arm(s) or of Arm(s) and Leg(s) in Cerebral Palsy (XARA)

Cerebral Palsy | Spasticity

Poland, Russian Federation, Ukraine, United States, Argentina, Mexico
Benha University

Completed

Botulium Toxin Type A In Non Infectious Chronic Rhinosinusitis

Chronic Rhinosinusitis (Diagnosis)

Egypt
Supernus Pharmaceuticals, Inc.

Completed

Efficacy and Safety Study of MYOBLOC® Followed by Open-Label Multiple-Treatment With MYOBLOC® in the Treatment of Troublesome Sialorrhea in Adult Subjects (MYSTICOL)

Sialorrhea

United States, Ukraine, Russian Federation
Ipsen

Completed

Dysport in Hallux Abducto Valgus (HAV) Phase IIa (DYSTANCE)

Hallux Abducto Valgus

United States
University of Central Florida

Terminated

The Effect of Abobotulinum Toxin A on the Symptoms of Raynaud's Phenomenon

Raynaud Phenomenon

United States
Assistance Publique - Hôpitaux de Paris
Recherche Clinique Paris Descartes Necker Cochin Sainte Anne

Completed

Efficacy of an Intra-articular Injection of Botulinum Toxin A Associated With Splinting for Base-of-thumb Osteoarthritis (RHIBOT)

Base-of-thumb Osteoarthritis

France
Izmir Katip Celebi University

Completed

Muscle Selection for Botulinum Toxin A Injection in Poststroke Elbow Flexor Spasticity

Muscle Spasticity

Turkey
Norwegian University of Science and Technology
St. Olavs Hospital

Completed

Botulinum Toxin Type A Block of the Otic Ganglion in Chronic Cluster Headache: Safety Issues

Cluster Headache

Norway
CHU de Reims

Terminated

Randomised, Evaluation-blinded, Crossover, Controlled Study Assessing Dynamic Hand Splinting in Adults With Post-stroke Hemiplegia (Orthox) (ORTHOX)

Upper Limb Spasticity

France
EvergreenHealth
The Cleveland Clinic

Completed

A Trial of Pelvic Floor Chemodenervation in Patients Undergoing Physical Therapy for High Tone Pelvic Floor Dysfunction

Pelvic Pain | Dyspareunia | Pelvic Floor Dysfunction

United States
Ipsen

Completed

A Study to Assess Treatment Outcomes of abobotulinumtoxinA and onabotulinumtoxinA Treatments in Real Life Practice in Toxin-naïve Adult Patients With Limb Spasticity.

Spasticity Related to Any Cause Except Cerebral Palsy

United Kingdom
Hospital Ambroise Paré Paris

Completed

Efficacy Study of Botox to Treat Neuropathic Pain

Postherpetic Neuralgia | Nerve Trauma

France
Direction Centrale du Service de Santé des Armées

Completed

Topical Aluminium Chloride vs OnabotulinumtoxinA Intradermal Injections in Residual Limb Hyperhidrosis (Lower Limbs) (SALUTOX)

Hyperhidrosis | Residual Limbs

France
Allergan

Completed

BOTOX® (onabotulinumtoxinA) Treatment of Masseter Muscle Prominence

Masseter Muscle Prominence

United States
Rajavithi Hospital

Completed

Abobotulinum Toxin and Neubotulinum Toxin Injection in Cerivical Dystonia (DNCD)

Cervical Dystonia

Thailand
Stanford University

Withdrawn

Botulinum Toxin Injection for Functional Popliteal Artery Entrapment Syndrome

Popliteal Artery Entrapment Syndrome | Functional Popliteal Artery Entrapment Syndrome

United States
Croma-Pharma GmbH

Completed

Princess® RICH for the Correction of Fine Lines (RICH)

Lateral Canthal Lines | Perioral Rhytids

Austria
David M. Simpson
Ipsen

Unknown

A Cross Over Pilot Study of Abobotulinum Toxin A (Dysport) as a Treatment for Task-dependent Upper Limb Tremor

Tremor, Limb

United States
Galderma R&D

Completed

Subjects' Satisfaction on Pan Facial Aesthetic Enhancement After Treatment With Azzalure® and the Restylane® Range (FIRST)

Aging

France, Spain, United Kingdom
Merz Pharmaceuticals GmbH

Completed

Botulinum Toxin A to Treat Arm Tremor

Essential Tremor of the Upper Limbs

United States, Canada
Galderma R&D

Completed

Comparison of Two Botulinum Toxins Type A on Forehead Wrinkles

Wrinkles

Germany
Alexandria University

Active, not recruiting

Clinical Evaluation of the Efficacy OF Botulinum Toxin A for Improving Facial Scars

Hypertrophic Scarring

Egypt
University Hospital, Toulouse
Merz Pharmaceuticals GmbH

Completed

Study of the Effects on Motor Recovery of Early Post-stroke Spasticity Treatment (BacloTox)

Muscle Spasticity

France
Brazilan Center for Studies in Dermatology
Allergan

Completed

Quality of Life and Self-esteem After Botox® Injections in Depressed and Non-depressed Patients

Depression | Quality of Life

Brazil
The University of Texas Health Science Center,...
Allergan

Completed

Comparative Efficacy of Three Preparations of Botox-A in Treating Spasticity

Stroke | Brain Injuries | Spasticity

United States
Ipsen

Completed

Dysport in Post-Surgical Neuralgia (PMOD03)

Chronic Scar Pain

United Kingdom
Baylor College of Medicine
U.S. Department of Education

Terminated

Botox-A Injection to Improve Bladder Function in Early Spinal Cord Injury (#H-20344)

Spinal Cord Injury | Neurogenic Bladder Dysfunction Nos

United States
DeNova Research
Allergan

Terminated

Botulinum Toxin A for Herpes Labialis

Herpes Labialis

United States
Ipsen

Completed

Effectiveness and Safety of Dysport® (abobotulinumtoxinA) in Paediatric Lower Limb Spasticity

Lower Limb Spasticity

United States

Search clinical trials for: abobotulinum toxin lateral orbital lines

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Hong Kong

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations